It is known that in vitro cells with G6PD knockdown are more susceptible to viral infections [42], and during the recent COVID-19 pandemic, G6PD deficiency was seen as an aggravating factor in the clinical picture and prognosis [37]. This evidence concerns the gene G6PD and hyperinsulinemic hypoglycemia, familial, 4.